Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
Journal
-
- The Lancet Respiratory Medicine
-
The Lancet Respiratory Medicine 9 (12), 1407-1418, 2021-12
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1360294645456564096
-
- ISSN
- 22132600
-
- Data Source
-
- Crossref